Lowenstein represented BTIG, LLC, Oppenheimer & Co. Inc., and B. Riley Securities, Inc. as sales agents in connection with an at-the-market offering of up to $150 million of common stock of Celularity, Inc. (NASDAQ:CELU), a clinical-stage biotechnology company focused on developing off-the-shelf therapies for the treatment of cancer and infectious and degenerative diseases.

The Lowenstein deal team included Steven M. Skolnick, Tracy F. Buffer, Robert J. Paradiso, Irina IshakBryan Weisgal, and Maxwell Berteletti.

About Lowenstein Sandler LLP
Lowenstein Sandler is a national law firm with over 350 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.

Contact(s):
Penny Paul
Sr. Manager, Marketing Communications
Lowenstein Sandler LLP
(973) 597-2592
ppaul@lowenstein.com